Telmisartan cas: 144701-48-4

CAS NO: 144701-48-4
Telmisartan
Description Review
Description

Telmisartan is a well-known medication used to treat high blood pressure. This article introduces the product and provides information about its molecular formula, CAS No, top ten Google search keywords, and synonyms. It also discusses the potential health benefits, potential effects, product mechanism, safety, side effects, dosing information, and concludes with an overall assessment of the medication.

Chemical name: 4'-[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid Molecular formula: C33H30N4O2 Formula weight: 514.62 g/mol CAS No: 144701-48-4

Top 10 Keywords and Synonyms:

  1. Telmisartan Dosage
  2. Telmisartan Side Effects
  3. Telmisartan for Hypertension
  4. Micardis Uses
  5. Micardis HCT
  6. Telmisartan and Ramipril
  7. Telmisartan Dose
  8. Telmisartan Vs Losartan
  9. Telmisartan Uses
  10. Telmisartan Half-life

Health Benefits of This Product: Telmisartan is primarily used to treat high blood pressure, also known as hypertension. By blocking the activity of angiotensin II, a hormone that causes vasoconstriction and raises blood pressure, Telmisartan helps to relax the blood vessels and thus lowers blood pressure. Lowering blood pressure reduces the risk of heart attack, stroke, and other cardiovascular diseases.

Potential Effects: Telmisartan's primary effect is to lower blood pressure, which leads to a decreased risk of cardiovascular events. It has also been shown to improve blood sugar levels and insulin sensitivity in some studies, making it a possible option to manage type 2 diabetes, which is often linked with high blood pressure.

Product Mechanism: Telmisartan belongs to a group of medications called angiotensin II receptor blockers (ARBs). It selectively blocks the binding of angiotensin II to the angiotensin II type 1 (AT1) receptors, which are responsible for vasoconstriction and other negative cardiovascular effects, leading to an overall reduction of blood pressure.

Safety: Telmisartan is generally considered safe, with very few severe side effects. It should not be used in pregnant women or those with a history of allergies to ARBs. Additionally, it should be used with caution in patients with kidney or liver diseases.

Side Effects: Common side effects of Telmisartan include dizziness, headache, and upset stomach. Other side effects that are less common include kidney problems, allergic reactions, and hyperkalemia.

Dosing Information: The starting dose of Telmisartan is usually 40mg per day, and it can be increased to 80mg per day if needed. The medication can be taken with or without food, and it's best to take it at the same time every day to ensure consistent results.

Conclusion: Telmisartan is a safe and effective medication for treating high blood pressure. It works by blocking the activity of angiotensin II, which causes vasoconstriction and hypertension. This medication has minimal side effects and is generally well-tolerated. Telmisartan is also effective for those with type 2 diabetes, a condition often linked to high blood pressure. Overall, Telmisartan is an effective choice for treating hypertension and reducing the risk of cardiovascular events when taken as directed by a healthcare professional.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code